Nghiên cứu hội chứng chuyển hóa -tim mạch- thận ở bệnh nhân đột quỵ não cấp
Tóm tắt
.
Lượt tải
Tài liệu tham khảo
1. Ndumele CE, Rangaswami J, Chow SL, Neeland IJ, Tuttle KR, Khan SS, et al. Cardiovascular-Kidney-Metabolic Health: A Presidential Advisory From the American Heart Association. Circulation. 2023; 148(20): 1606-1635. https://doi.org/10.1161/CIR.0000000000001184
2. Sacco RL, Kasner SE, Broderick JP, Caplan LR, Connors JJ, Culebras A, et al. An Updated Definition of Stroke for the 21st Century. Stroke. 2013; 44(7): 2064-2089. https://doi.org/doi:10.1161/STR.0b013e318296aeca
3. Inoue S, Zimmet P. The Asia-Pacific perspective: Redefining obesity and its treatment. 2000: Health Communications Australia Pty Limited.
4. Huỳnh văn Minh, Trần Văn Huy, Phạm Gia Khải, Đặng Vạn Phước, Khuyến cáo về chẩn đoán và điều trị tăng huyết áp. 2018, Hội Tim Mạch Học Quốc Gia Việt Nam.
5. European Association for Cardiovascular Prevention and Rehabilitation. E. S. C. Committee for Practice Guidelines Committees. ESC/EAS Guidelines for the management of dyslipidaemias: the Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS). Eur Heart J. 2011; 32(14): 1769-818. https://doi.org/10.1093/eurheartj/ehr158
6. Committee ADAPP. 2. Diagnosis and Classification of Diabetes: Standards of Care in Diabetes—2024. Diabetes Care. 2023; 47(Supplement_1): S20-S42. https://doi.org/10.2337/dc24-S002
7. Alberti K. G., Eckel R. H., Grundy S. M., Zimmet PZ, Cleeman JI, Donato KA, et al. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation. 2009; 120(16): 1640-5. https://doi.org/10.1161/CIRCULATIONAHA.109.192644
8. Levin A, Stevens P, Bilous RW, Coresh J, Francisco A, Jong PE, et al. Kidney disease: Improving global outcomes (KDIGO) CKD work group. KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney International Supplements. 2013; 3: 1-150. https://doi.org/10.1038/kisup.2012.73
9. Akyea RK, Vinogradova Y, Qureshi N, Patel RS, Kontopantelis E, Ntaios G, et al. Sex, Age, and Socioeconomic Differences in Nonfatal Stroke Incidence and Subsequent Major Adverse Outcomes. Stroke. 2021; 52(2): 396-405. https://doi.org/10.1161/STROKEAHA.120.031659
10. Jankowski J, Floege J, Fliser D, Bohm M, Marx N. Cardiovascular Disease in Chronic Kidney Disease: Pathophysiological Insights and Therapeutic Options. Circulation. 2021; 143(11): 1157-1172. https://doi.org/10.1161/CIRCULATIONAHA.120.050686
11. American Diabetes Association Professional Practice Committee. Chronic Kidney Disease and Risk Management: Standards of Care in diabetes—2024. Diabetes Care 2024; 47: s219-s230. https://doi.org/10.2337/dc24-S011
12. Delanaye P, Glassock RJ, Pottel H, Rule AD. An Age-Calibrated Definition of Chronic Kidney Disease: Rationale and Benefits. (0159-8090 (Print)).
13. Kawamoto R, Kohara K Fau - Tabara Y, Tabara Y Fau - Miki T, Miki T Fau - Ohtsuka N, Ohtsuka N Fau - Kusunoki T, Kusunoki T Fau - Yorimitsu N, et al. An association between body mass index and estimated glomerular filtration rate. 2008(0916-9636 (Print)).
14. Garofalo C, Borrelli S, Minutolo R, Chiodini P, De Nicola L, Conte G. A systematic review and meta-analysis suggests obesity predicts onset of chronic kidney disease in the general population. Kidney International. 2017; 91(5): 1224-1235. https://doi.org/https://doi.org/10.1016/j.kint.2016.12.013
